Actively Recruiting

Age: 45Years - 75Years
All Genders
Healthy Volunteers
ID07077967

Impact of Artificial Lighting on Visual Acuity After Presbyopia Correction With an Extended Depth of Focus Intraocular Lens: Introduction of a Modified Luminous Efficiency Function V(λ)'

Led by Democritus University of Thrace · Updated on 2026-02-24

100

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying how extended-depth of focus (EDOF) intraocular lenses (IOLs) used in pseudophakic presbyopic correction affect eye light transmission and visual acuity. The study aims to develop a modified luminous efficiency function to better understand the total eye light transmittance in patients with these lenses. This observational study focuses on identifying lighting needs and adjustments for patients after implantation of EDOF IOLs compared to those with monofocal IOLs. Participants include two groups: those who had pseudophakic presbyopic correction with yellow filter EDOF IOLs like Vivity or Vivity toric, and a control group of similar age with monofocal or monofocal toric IOLs implanted during cataract surgery. The study observes natural outcomes without intervention, measuring how these different lenses influence the minimum light intensity needed for maximum visual acuity. During the study, participants’ visual acuity and eye light transmission will be assessed, focusing on the minimum required illuminance level six months after surgery. Researchers will examine visual performance under varying lighting conditions to determine appropriate lighting adjustments. Participants can expect periodic evaluations to measure their vision and light sensitivity as part of this study lasting up to six months postoperatively.

CONDITIONS

Brief Title

Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs

Who Can Participate

Age: 45Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 45 to 75 years
Not Eligible

You will not qualify if you...

  • Astigmatism greater than 1.00 diopters
  • Glaucoma
  • Former incisional eye surgery
  • Corneal or fundus disease
  • Diabetes mellitus
  • Autoimmune diseases
  • Neurological or psychiatric diseases
  • Posterior capsule rupture or lens misalignment
  • Postoperative uncorrected distance visual acuity less than 8/10

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Long-term Monitoring

Duration - 6 months postoperatively

Participants who underwent pseudophakic presbyopic correction with EDOF IOLs or monofocal IOLs are observed to evaluate visual acuity under different lighting conditions.

Trial Site Locations

Total: 1 location

1

University Hospital of Alexandroupolis

Alexandroupoli, Evros, Greece, 68100

Actively Recruiting

Loading map...

Research Team

E

Eirini - Kanella Panagiotopoulou, MD, MSc, PhD

G

Georgios Labiris, MD, Prof

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Clinical Applications of Advanced Ophthalmic Imaging Using O...

Multiple Sclerosis

Actively Recruiting

1 location

Clinical Performance of Verofilcon A Toric Contact Lenses in...

Contact Lenses

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Lighting Standards Revisited: Introduction of a Mathematical Model for the Assessment of the Impact of Illuminance on Visual Acuity.

Georgios Labiris, Eirini-Kanella Panagiotopoulou, Sergios Taliantzis...

https://pubmed.ncbi.nlm.nih.gov/34866900